Olopatadine
Intranasal
Ophthalmic
Class
Antihistamines
Subclass
Second-generation H1-antihistamines
Substance name
Olopatadine hydrochloride
Brand names
Patanase®
Common formulations
Nasal spray
Contained in
Olopatadine / mometasone (Ryaltris®)
Dosage and administration
Adults patients
Symptomatic relief of allergic rhinitis • Seasonal
Indications for use
Labeled indications
Adults
Safety risks
Contraindications
Hypersensitivity to olopatadine or its components
Concomitant use of alcohol or other CNS depressants
Warnings and precautions
Nosebleed, nasal ulcers, nasal septum perforation
Somnolence
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: B1
Breastfeeding
Use only if benefits outweigh potential risks.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Uncommon < 1%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource